跳至主要内容
临床试验/ACTRN12613000700730
ACTRN12613000700730已完成3 期

Vitamin D deficient adolescents randomised to 50000 international units (IU) of vitamin D3 given orally monthly or 150000 IU of vitamin D3 given orally 3-monthly or placebo given monthly and 3-monthly, assessed by correcting vitamin D deficiency, feasibility of recruiting adolescents using general practice, and obtaining pilot bone density outcome data.

Menzies Research Institute Tasmania, University of Tasmania0 个研究点目标入组 33 人开始时间: 2013年6月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
15 Years 至 17 Years(—)
性别
All

入选标准

  • Healthy adolescents aged 15-17 years.
  • Mild to moderate vitamin D deficiency (serum 25-OHD 12.5-50 nmol/L).
  • No known severe renal impairment, malabsorption, pregnancy, or lactation.
  • No clinical signs of rickets.
  • No reason known to GP to prevent participation or which makes making contact with the young person inappropriate (there may be cases where for reasons of patient confidentiality the GP will not wish a letter to be sent to a young person’s parents for example).

排除标准

  • Normal vitamin D levels (serum 25-OHD > 50 nmol/L).
  • Severe vitamin D deficiency (serum 25-OHD < 12.5 nmol/L). These patients will be referred to their GP for assessment and consideration of treatment. We will send a copy of these results together with a letter outlining appropriate treatment advice to the GP.
  • Known severe renal impairment, malabsorption, pregnancy, or lactation.
  • Clinical signs of rickets.

研究者

发起方
Menzies Research Institute Tasmania, University of Tasmania

相似试验